Global Cell Freezing Media for Cell Therapy Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031

According to our (Global Info Research) latest study, the global Cell Freezing Media for Cell Therapy market size was valued at US$ 88.2 million in 2024 and is forecast to a readjusted size of USD 204 million by 2031 with a CAGR of 12.9% during review period.

Cell freezing medium is a complete cell freezing media for mammalian cell cultures. Most classic formulations of cell freezing media containing dimethyl sulfoxide (DMSO) as the active freezing agent. However, since it is known that DMSO is a mutagen and carcinogen, DMSO-free formulations are becoming popular for stem cell applications. This is an especially critical consideration for cells being used in translational research or clinical applications. Moreover, media formulations that are manufactured under GMP compliance and have drug-master files registered with government regulatory agencies provide added value for regenerative medicine use.

Market Driver for Cell Freezing Media for Cell Therapy

The increasing adoption of cell-based therapies in regenerative medicine and immunotherapy is a primary driver for the growth of the cell freezing media market. As the demand for stem cell therapy, gene therapy, and other cellular therapies grows, the need for efficient cryopreservation methods to store and transport cells has become more critical. Cell freezing media are essential for preserving cell viability and functionality during the freezing and thawing processes. Advances in freezing media formulations, which enhance cell survival rates and reduce damage during storage, are further driving market growth. Additionally, the expansion of research activities and clinical trials in cell therapy is fueling the demand for specialized cryopreservation products.

Market Challenge for Cell Freezing Media for Cell Therapy

Despite the increasing demand for cell freezing media, the market faces challenges related to the complexity and cost of these products. The formulations of freezing media can be highly specialized depending on the cell type, and the optimization of these media for different applications can be time-consuming and costly. Another challenge is the lack of standardized protocols for cryopreservation, which can lead to variability in outcomes across different laboratories and clinical settings. Additionally, regulatory hurdles and the need for extensive validation studies to ensure the safety and efficacy of freezing media in therapeutic applications can slow market adoption. These factors create obstacles for widespread and cost-effective implementation of cell freezing media in cell therapy.

Market competition is intense. BioLife Solutions, Thermo Fisher Scientific, Merck, Cytiva, Zenoaq, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers. The Top 5 manufacturers occupied 87% of global market share in 2023.

This report is a detailed and comprehensive analysis for global Cell Freezing Media for Cell Therapy market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.

Key Features:

Global Cell Freezing Media for Cell Therapy market size and forecasts, in consumption value ($ Million), sales quantity (Liters), and average selling prices (USD/Liter), 2020-2031

Global Cell Freezing Media for Cell Therapy market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Liters), and average selling prices (USD/Liter), 2020-2031

Global Cell Freezing Media for Cell Therapy market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Liters), and average selling prices (USD/Liter), 2020-2031

Global Cell Freezing Media for Cell Therapy market shares of main players, shipments in revenue ($ Million), sales quantity (Liters), and ASP (USD/Liter), 2020-2025

The Primary Objectives in This Report Are:

To determine the size of the total market opportunity of global and key countries

To assess the growth potential for Cell Freezing Media for Cell Therapy

To forecast future growth in each product and end-use market

To assess competitive factors affecting the marketplace

This report profiles key players in the global Cell Freezing Media for Cell Therapy market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include BioLife Solutions, Thermo Fisher Scientific, Merck, Cytiva, Zenoaq, WAK-Chemie Medical, Sartorius, Akron Biotechnology, Sansheng Bio, Yoon, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Market Segmentation

Cell Freezing Media for Cell Therapy market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
With FBS
Without FBS

Market segment by Application
Human Embryonic Stem Cells
CAR-T Cell Therapy
Neural Stem Cell Therapy
Mesenchymal Stem Cell Therapy
Hematopoietic Stem Cell Transplantation
Others

Major players covered
BioLife Solutions
Thermo Fisher Scientific
Merck
Cytiva
Zenoaq
WAK-Chemie Medical
Sartorius
Akron Biotechnology
Sansheng Bio
Yoon

Market segment by region, regional analysis covers

North America (United States, Canada, and Mexico)

Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)

South America (Brazil, Argentina, Colombia, and Rest of South America)

Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:

Chapter 1, to describe Cell Freezing Media for Cell Therapy product scope, market overview, market estimation caveats and base year.

Chapter 2, to profile the top manufacturers of Cell Freezing Media for Cell Therapy, with price, sales quantity, revenue, and global market share of Cell Freezing Media for Cell Therapy from 2020 to 2025.

Chapter 3, the Cell Freezing Media for Cell Therapy competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Cell Freezing Media for Cell Therapy breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.

Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.

Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Cell Freezing Media for Cell Therapy market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.

Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.

Chapter 13, the key raw materials and key suppliers, and industry chain of Cell Freezing Media for Cell Therapy.

Chapter 14 and 15, to describe Cell Freezing Media for Cell Therapy sales channel, distributors, customers, research findings and conclusion.